Investment Strategies: Analyzing EAM Investors, LLC Q3 2022 vs. Q4 2022 Holdings

Investment strategies are always evolving, and with that comes the need to analyze recent changes in holdings. In this blog post, we will take a look at the holdings of EAM Investors, LLC, comparing Q3 2022 to Q4 2022. By analyzing changes in share counts and value, we can gain insight into the investment strategy of EAM Investors and the market trends that may be driving these changes.

ADMA Biologics Inc: A Nearly 100% Increase in Share Count

EAM Investors made a significant increase in their holdings of ADMA Biologics Inc between Q3 and Q4 of 2022. The number of shares held increased from 1,427,160 in Q3 to 1,749,598 in Q4, a change of 22% and an increase of nearly 100%. Additionally, the value of the shares held in ADMA Biologics Inc increased from $3,468,000 to $6,788,000, making it one of the top performers in EAM Investors' portfolio in Q4 of 2022.

UFP Technologies Inc: A Steady Increase in Share Count

EAM Investors' holdings in UFP Technologies Inc increased steadily during the period, rising from 42,412 in Q3 to 49,672 in Q4. While this is only a 17% increase, the share count growth is consistent. In terms of value, the change is more significant, rising from $3,641,000 in Q3 to $5,855,000 in Q4, an increase of 60.8%. When considering the steady increase in share count and significant increase in value, it's clear that EAM Investors sees a future in UFP Technologies Inc.

Rhythm Pharmaceuticals Inc: A Decrease in Share Count and Value

While EAM Investors increased their holdings in many companies between Q3 and Q4 of 2022, there were a few where they decreased their holdings. Rhythm Pharmaceuticals Inc was one such company. While EAM Investor held 198,699 shares of the company in Q3, this number decreased to 164,695 in Q4. Additionally, the value of these shares dropped from $4,868,000 to $4,795,000, a decrease of 1.5%. While there may be many reasons for the decrease, it's clear that EAM Investors decided to reduce their holdings in this company.

Viking Therapeutics Inc: A Significant Increase in Share Count

EAM Investors' holdings of Viking Therapeutics Inc increased significantly between Q3 and Q4 of 2022. While they held no shares in the company in Q3, they held 494,940 shares in Q4, representing a percentage increase that cannot be precisely calculated. However, the value of these shares was $4,652,000, making this one of the top-performing companies in EAM Investor's portfolio in Q4 of 2022.

CECO Environmental Corp: A Steady Increase in Share Count and Value

CECO Environmental is another company where EAM Investors' holdings increased steadily between Q3 and Q4 of 2022. The share count increased from 364,519 in Q3 to 363,995 in Q4, a slight decrease of 0.14%. However, the value of these shares increased from $3,226,000 to $4,251,000, a significant increase of 31.8%. This consistent increase in value and steady share count growth suggests that EAM Investors sees a future in CECO Environmental Corp.

Conclusion

In conclusion, EAM Investors' Q3 vs. Q4 2022 analysis of their 13F holdings tells us a lot about their investment strategies. While they increased their holdings in many companies, there were still others where they decided to decrease or sell their holdings. By analyzing the data presented above, we can gain insight into the market trends that are driving these decisions and better understand the investment strategies of EAM Investors.